Stimulant Use Disorder: Treatment Review and Future Therapies 3.21.24
Allegheny County Medical Society
https://cce.upmc.com/content/stimulant-use-disorder-treatment-review-and-future-therapies-32124
Code: CODNAM
Target Audience
Physicians
Learning Objectives
• Briefly review the pharmacology and neurobiology of stimulants
• Discuss the epidemiology of stimulant use and Stimulant Use Disorder in the United States
• Explore the history of stimulant use and the medico-legal considerations in treating Stimulant Use Disorder
• Review various pharmacological interventions that have been studied for the treatment of Stimulant Use Disorder
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
James Latronica, DO
Disclosure Statement: No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
Accreditation and credit designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and qualifies for Patient Safety-Risk Management Credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Patient Safety/Risk Management
- 1.00 Attendance